Low-dose human chorionic gonadotropin therapy can improve sensitivity to exogenous follicle-stimulating hormone in patients with secondary amenorrhea

Authors:
  • GCGraciela E Cognigni
    Graciela E Cognigni
  • STStefania Taraborrelli
    Stefania Taraborrelli
  • DSDaniela Spettoli
    Daniela Spettoli
  • WCWalter Ciampaglia
    Walter Ciampaglia
  • CFCristina Tabarelli de Fatis
    Cristina Tabarelli de Fatis

Abstract
No abstract available